2011Chinese Journal of Health Laboratory TechnologyRequires access

β-lactamase gene analysis of ceftazidime-resistant Enterobacter cloacae

Qiaoyun Li, Ting Cai, Yanzi Chang, Shun Zhang

Open publisher page 0 citations

Abstract

Objective:To analyze the drug resistence and common β-lactamase gene distribution in clinical isolates resistant to ceftazidime-resistant Enterobacter cloacae.Methods: The antimicrobial susceptibility of clinical isolates of Enterobacter cloacae was tested in vitro;then nine β-lactamase genes(including the TEM) were amplified by PCR.Results: Of 42 ceftazidime-resistant Enterobacter cloacae,34(80.95%) were ESBL producer,and the resistance was higher in non-ESBL producing strains ESBL producing strains to some antibiotics.The drug-resistance gene detection rates of TEM,SHV,CTX-M,DHA,EBC,CIT,KPC were 35.7%,50.0%,19.0%,9.5%,97.6%,28.6%,2.4%.We didn′t find IMP and VIM resistance genes in these strains.Conclusion: There was a higher detection rate of β-lactamase gene in ceftazidime-resistant Enterobacter cloacae,and there were a variety of resistance mechanisms of Enterobacter cloacae.

About this research paper

What this paper is about

Objective:To analyze the drug resistence and common β-lactamase gene distribution in clinical isolates resistant to ceftazidime-resistant Enterobacter cloacae.Methods: The antimicrobial susceptibility of clinical isolates of Enterobacter cloacae was tested in vitro;then nine β-lactamase genes(including the TEM) were amplified by PCR.Results: Of 42 ceftazidime-resistant Enterobacter cloacae,34(80.95%) were ESBL producer,and the resistance was higher in non-ESBL producing strains ESBL producing strains to some antibiotics.The drug-resistance gene detection rates of TEM,SHV,CTX-M,DHA,EBC,CIT,KPC were 35.7%,50.0%,19.0%,9.5%,97.6%,28.6%,2.4%.We didn′t find IMP and VIM resistance genes in these strains.Conclusion: There was a higher detection rate of β-lactamase gene in ceftazidime-resistant Enterobacter cloacae,and there were a variety of resistance mechanisms of Enterobacter cloacae.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To analyze the drug resistence and common β-lactamase gene distribution in clinical isolates resistant to ceftazidime-resistant Enterobacter cloacae.Methods: The antimicrobial susceptibility of clinical isolates of Enterobacter cloacae was tested in vitro;then nine β-lactamase genes(including the TEM) were amplified by PCR.Results: Of 42 ceftazidime-resistant Enterobacter cloacae,34(80.95%) were ESBL producer,and the resistance was higher in non-ESBL producing strains ESBL producing strains to some antibiotics.The drug-resistance gene detection rates of TEM,SHV,CTX-M,DHA,EBC,CIT,KPC were 35.7%,50.0%,19.0%,9.5%,97.6%,28.6%,2.4%.We didn′t find IMP and VIM resistance genes in these strains.Conclusion: There was a higher detection rate of β-lactamase gene in ceftazidime-resistant Enterobacter cloacae,and there were a variety of resistance mechanisms of Enterobacter cloacae.

Key concepts: Enterobacter cloacae, Ceftazidime, Microbiology, Enterobacter, Biology, Drug resistance, Antibiotics, Antibiotic resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
β-lactamase gene analysis of ceftazidime-resistant Enterobacter cloacae — Research Paper | ScholarLens